The estimated Net Worth of Richard E Caruso is at least $304 Million dollars as of 18 June 2020. Dr Caruso owns over 600,000 units of Integra Lifesciences Corp stock worth over $181,125,208 and over the last 21 years he sold IART stock worth over $122,537,977.
Dr has made over 19 trades of the Integra Lifesciences Corp stock since 2006, according to the Form 4 filled with the SEC. Most recently he sold 600,000 units of IART stock worth $29,082,000 on 18 June 2020.
The largest trade he's ever made was selling 600,000 units of Integra Lifesciences Corp stock on 18 June 2020 worth over $29,082,000. On average, Dr trades about 67,932 units every 144 days since 2003. As of 18 June 2020 he still owns at least 10,291,205 units of Integra Lifesciences Corp stock.
You can see the complete history of Dr Caruso stock trades at the bottom of the page.
Dr. Richard E. Caruso is the Founder and Chairman Emeritus at Integra Lifesciences Corp.
Dr Caruso is 78, he's been the Founder and Chairman Emeritus of Integra Lifesciences Corp since . There are no older and 21 younger executives at Integra Lifesciences Corp.
Richard's mailing address filed with the SEC is 795 E LANCASTER AVENUE, SUITE 200, , VILLANOVA, PA, 19085.
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig, and George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
Integra Lifesciences Corp executives and other stock owners filed with the SEC include: